Page last updated: 2024-08-24

5-methylcytosine and Uterine Cervical Neoplasms

5-methylcytosine has been researched along with Uterine Cervical Neoplasms in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (28.57)	29.6817
2010's	4 (57.14)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Asanoma, K; Cui, L; Hori, E; Itakura, A; Kato, K; Kato, M; Kawakami, M; Kawamura, K; Kodama, K; Matsumura, Y; Onoyama, I; Takeda, S; Yagi, H; Yahata, H; Yoshida, S	1
Bhat, S; Chakrabarty, S; Kabekkodu, SP; Kushtagi, P; Mallya, SP; Pandey, D; Rotti, H; Satyamoorthy, K; Varghese, VK	1
Balch, C; Chao, TK; Chen, CW; Chen, LY; Hsu, YW; Huang, RL; Lai, HC; Liao, CC; Mao, SP; Su, PH; Wu, TI	1
Ding, Y; Su, Y; Tian, Y; Wang, J; Wang, X	1
Han, CS; Li, PL; Zhang, LY; Zhang, XC	1
Angeles, E; Cabrera, G; Cetina, L; Chanona-Vilchis, J; Chavez-Blanco, A; Duenas-González, A; Perez-Cardenas, E; Revilla-Vazquez, A; Sandoval, K; Segura-Pacheco, B; Taja-Chayeb, L; Trejo-Becerril, C; Zambrano, P	1
Azrad, M; Brill, I; Grizzle, WE; Jhala, D; Jhala, N; Kabagambe, EK; Macaluso, M; Niveleau, A; Piyathilake, CJ	1

Trials

1 trial(s) available for 5-methylcytosine and Uterine Cervical Neoplasms

Article	Year
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC cancer, 2005, Apr-29, Volume: 5 Topics: 5-Methylcytosine; Adult; Aged; Binding Sites; Biopsy; Cardiovascular Diseases; Cohort Studies; Cytosine; DNA; DNA Methylation; Electrophoresis, Capillary; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Hydralazine; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Long Noncoding; RNA, Untranslated; Uterine Cervical Neoplasms; Vasodilator Agents	2005

Article

Year

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes.

BMC cancer, 2005, Apr-29, Volume: 5

Topics: 5-Methylcytosine; Adult; Aged; Binding Sites; Biopsy; Cardiovascular Diseases; Cohort Studies; Cytosine; DNA; DNA Methylation; Electrophoresis, Capillary; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Hydralazine; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Long Noncoding; RNA, Untranslated; Uterine Cervical Neoplasms; Vasodilator Agents

2005

Other Studies

6 other study(ies) available for 5-methylcytosine and Uterine Cervical Neoplasms

Article	Year
Downregulation of 5-hydroxymethylcytosine is associated with the progression of cervical intraepithelial neoplasia. PloS one, 2020, Volume: 15, Issue:11 Topics: 5-Methylcytosine; Animals; Cytidine Deaminase; DNA (Cytosine-5-)-Methyltransferase 1; Down-Regulation; Female; Humans; Mice, Inbred C57BL; Minor Histocompatibility Antigens; Mixed Function Oxygenases; Proto-Oncogene Proteins; Tumor Suppressor Protein p53; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	2020
Aberrant gene-specific DNA methylation signature analysis in cervical cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:3 Topics: 5-Methylcytosine; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; DNA Methylation; Female; Genotype; High-Throughput Nucleotide Sequencing; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Humans; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Papillomaviridae; Promoter Regions, Genetic; Transcription Factors; Uterine Cervical Neoplasms	2017
TET1 promotes 5hmC-dependent stemness, and inhibits a 5hmC-independent epithelial-mesenchymal transition, in cervical precancerous lesions. Cancer letters, 2019, 05-28, Volume: 450 Topics: 5-Methylcytosine; Animals; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; HeLa Cells; Heterografts; Humans; Mice; Mixed Function Oxygenases; Neoplastic Stem Cells; Precancerous Conditions; Proto-Oncogene Proteins; Squamous Intraepithelial Lesions of the Cervix; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vimentin; Zinc Finger E-box-Binding Homeobox 1	2019
Characterization of DNA hydroxymethylation profile in cervical cancer. Artificial cells, nanomedicine, and biotechnology, 2019, Volume: 47, Issue:1 Topics: 5-Methylcytosine; Adult; DNA Methylation; Female; Genomics; Humans; Transcription, Genetic; Uterine Cervical Neoplasms	2019
5-Hydroxymethylcytosine expression is associated with poor survival in cervical squamous cell carcinoma. Japanese journal of clinical oncology, 2016, Volume: 46, Issue:5 Topics: 5-Methylcytosine; Adult; Carcinoma, Squamous Cell; Cervix Uteri; Dioxygenases; Disease-Free Survival; DNA-Binding Proteins; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Mixed Function Oxygenases; Multivariate Analysis; Prognosis; Proto-Oncogene Proteins; Uterine Cervical Neoplasms	2016
Mandatory fortification with folic acid in the United States is not associated with changes in the degree or the pattern of global DNA methylation in cells involved in cervical carcinogenesis. Cancer biomarkers : section A of Disease markers, 2006, Volume: 2, Issue:6 Topics: 5-Methylcytosine; Adult; Antibodies, Monoclonal; Cell Transformation, Neoplastic; DNA Methylation; Edible Grain; Female; Folic Acid; Food, Fortified; Humans; Immunohistochemistry; Middle Aged; United States; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	2006